Tyme Technologies, Inc. (TYME) Stock Trends downwards Following Strong Q4 2021 Financials and Progress in OASIS Trial
Tyme Technologies, Inc. (TYME) stock prices was down by -6.92% shortly after market trading commenced on June 11th, 2021, bringing the price per share up to USD$1.48 early on in the trading day. Solid Liquidity Position The company reported a stellar liquidity position at the end of the fourth quarter of fiscal 2021, with cash […]
Vaxart, Inc. (VXRT) Stock Trending Higher Following Enrollment of First Patient in Norovirus Clinical Trial
Vaxart, Inc. (VXRT) stock prices were up by 6.84% as of the market closing on June 7th, 2021, bringing the price per share up to USD$7.34 at the end of the trading day. Subsequent pre-market fluctuations have seen the stock rise by 4.22%, bringing it up to USD$7.65. Get the hottest stocks to trade every […]
PDS Biotechnology Corp. (PDSB) Stock Rallies Following Inclusion in Russell Microcap Index
PDS Biotechnology Corp. (PDSB) stock prices were down by a concerning 26.45% as of the market closing on June 7th, 2021, bringing the price per share down to USD$9.40 at the end of the trading day. Subsequent pre-market fluctuations saw the stock rise by 8.51%, bringing it up to USD$10.20. Inclusion in Russell Microcap Index […]
BriaCell Therapeutics Corp. (BCTX) Stock Skyrockets Following Disclosure of Overall Survival (OS) Reports
BriaCell Therapeutics Corp. (BCTX) stock prices were down by a marginal 2.75% as of the market closing on June 1st, 2021, bringing the price per share up to USD$3.18 at the end of the trading day. Subsequent current market fluctuations have seen the stock skyrocket by 99.69% to hit USD$6.35. OS Update The clinical stage […]
Novan, Inc. (NOVN) Stock Plummets Following Reverse Stock Split of its Common Stock
Novan, Inc. (NOVN) stock prices were up by 7.69% as of the market closing on May 24th, 2021, bringing the price per share up to USD$1.40 at the end of the trading day. Subsequent current market fluctuations have seen the stick plummet by 33.43%, bringing the price per share down to USD$0.93. Get the hottest […]
AnPac Bio-Medical Science Co., Ltd. (ANPC) Stock Surges Following Announcement of Joint Venture
AnPac Bio-Medical Science Co., Ltd. (ANPC) stock prices were up by 3.08% as of the market closing on May 24th, 2021, bringing the price per share up to USD$4.68 at the end of the trading day. Subsequent pre-market fluctuations saw the stock skyrocket by 19.87%, bringing it up to USD$5.61. Joint Venture Approved The company’s […]
ThermoGenesis Holdings, Inc. (THMO) Stock Continues Trending Up With Easing of Pandemic Restrictions
ThermoGenesis Holdings, Inc. (THMO) stock prices were up by 5.83% as of the market closing on May 24th, 2021, bringing the price per share up to USD$2.54 at the end of the trading day. PXP-LAVARE Progress The company announced early in February of 2021 that it had finished the process of developing its innovative PXP-LAVARE […]
Cellect Biotechnology Ltd. (APOP) Stock Trending Higher as Cannabis Sector Booms
Cellect Biotechnology Ltd. (APOP) stock prices were up by 4.09% as of the market closing on May 21st, 2021, bringing the price per share up to USD$2.80 at the end of the trading day. Subsequent pre-market fluctuations saw the price rise by 2.86%, up to USD$2.88. Improved Revenue Reports The company reported highly promising improvements […]
Amgen, Inc. (AMGN) Stock Prices Undergo Volatility as Global Pandemic on Verge of Easing Up
Amgen, Inc. (AMGN) stock prices were down a marginal 0.15% as of market close on April 27th, 2021, inching the price down to USD$255.13. Subsequent pre-market fluctuations saw the stock price fall by 3.38%, bringing the price per share down to USD$246.50. Total Revenues Suffer The COVID-19 pandemic has been devastating for Amgen since its […]
Vaxart, Inc. (VXRT) Stock Prices Skyrocket Following Announcement of T-cell Webinar
Vaxart, Inc. (VXRT) stock prices were up a staggering 37.46% as of market close on April 27th, 2021, bringing the price per share up to USD$8.33. Novel COVID-19 Tablet With the world hurtling towards COVID-19 solutions for the pandemic, VXRT is setting itself apart from its competitors with a drug, VXA-CoV2-1, that comes in tablet […]
